Cover Image
市場調查報告書

Enzo Biochem, Inc. - 產品平台檢討

Enzo Biochem, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 207935
出版日期 內容資訊 英文 33 Pages
訂單完成後即時交付
價格
Back to Top
Enzo Biochem, Inc. - 產品平台檢討 Enzo Biochem, Inc. - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 33 Pages
簡介

Enzo Biochem, Inc. (Biochem) 身為一個綜合性生命科學生物科技企業,正開發利用生物學過程的研究工具、診斷法,以及治療法。此外更基於分子細胞技術研究開發、製造、專利授權、產品化創新醫療保健產品、平台及服務。

本報告提供Enzo Biochem, Inc.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Enzo Biochem, Inc.的基本資料

Enzo Biochem, Inc.概要

  • 主要資訊
  • 企業資料

Enzo Biochem, Inc.:R&D概要

  • 主要的治療範圍

Enzo Biochem, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Enzo Biochem, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Enzo Biochem, Inc.:藥物簡介

  • Alequel
  • HGTV-43
  • Optiquel
  • Enzo-D58
  • Small Molecule To Modulate LRP For Diabetes
  • Small Molecule To Modulate LRP For Osteonecrosis Of Jaws
  • Small Molecule To Modulate LRP For Osteoporosis
  • Small Molecules As WNT Modulators For Cancer

Enzo Biochem, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

Enzo Biochem, Inc.:最近的開發平台趨勢

Enzo Biochem, Inc.:暫停中的計劃

Enzo Biochem, Inc.:企業發表

Enzo Biochem, Inc.:總公司和子公司的所地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07708CDB

Summary

Global Markets Direct's, 'Enzo Biochem, Inc. - Product Pipeline Review - 2015', provides an overview of the Enzo Biochem, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Enzo Biochem, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Enzo Biochem, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Enzo Biochem, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Enzo Biochem, Inc.'s pipeline products

Reasons to buy

  • Evaluate Enzo Biochem, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Enzo Biochem, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Enzo Biochem, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Enzo Biochem, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Enzo Biochem, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Enzo Biochem, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Enzo Biochem, Inc. Snapshot
    • Enzo Biochem, Inc. Overview
    • Key Information
    • Key Facts
  • Enzo Biochem, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Enzo Biochem, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Enzo Biochem, Inc. - Pipeline Products Glance
    • Enzo Biochem, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Enzo Biochem, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Enzo Biochem, Inc. - Drug Profiles
    • Alequel
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • B27-PD
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • EGS-21
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HGTV-43
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Enzo-D58
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize LRP for Osteonecrosis Of Jaws
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize LRP for Osteoporosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize LRP for Type 2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Colorectal Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Enzo Biochem, Inc. - Pipeline Analysis
    • Enzo Biochem, Inc. - Pipeline Products by Target
    • Enzo Biochem, Inc. - Pipeline Products by Route of Administration
    • Enzo Biochem, Inc. - Pipeline Products by Molecule Type
    • Enzo Biochem, Inc. - Pipeline Products by Mechanism of Action
  • Enzo Biochem, Inc. - Recent Pipeline Updates
  • Enzo Biochem, Inc. - Dormant Projects
  • Enzo Biochem, Inc. - Company Statement
  • Enzo Biochem, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Enzo Biochem, Inc., Key Information
  • Enzo Biochem, Inc., Key Facts
  • Enzo Biochem, Inc. - Pipeline by Indication, 2015
  • Enzo Biochem, Inc. - Pipeline by Stage of Development, 2015
  • Enzo Biochem, Inc. - Monotherapy Products in Pipeline, 2015
  • Enzo Biochem, Inc. - Phase II, 2015
  • Enzo Biochem, Inc. - Preclinical, 2015
  • Enzo Biochem, Inc. - Pipeline by Target, 2015
  • Enzo Biochem, Inc. - Pipeline by Route of Administration, 2015
  • Enzo Biochem, Inc. - Pipeline by Molecule Type, 2015
  • Enzo Biochem, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Enzo Biochem, Inc. - Recent Pipeline Updates, 2015
  • Enzo Biochem, Inc. - Dormant Developmental Projects,2015
  • Enzo Biochem, Inc., Subsidiaries

List of Figures

  • Enzo Biochem, Inc. - Pipeline by Top 10 Indication, 2015
  • Enzo Biochem, Inc. - Pipeline by Stage of Development, 2015
  • Enzo Biochem, Inc. - Monotherapy Products in Pipeline, 2015
  • Enzo Biochem, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Enzo Biochem, Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top